142 related articles for article (PubMed ID: 35618000)
1. LAT1, a novel pharmacological target for the treatment of glioblastoma.
Cappoli N; Jenkinson MD; Dello Russo C; Dickens D
Biochem Pharmacol; 2022 Jul; 201():115103. PubMed ID: 35618000
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
3. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
Kanai Y
Pharmacol Ther; 2022 Feb; 230():107964. PubMed ID: 34390745
[TBL] [Abstract][Full Text] [Related]
4. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
[TBL] [Abstract][Full Text] [Related]
5. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
Lu X
Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820
[TBL] [Abstract][Full Text] [Related]
6. Large Amino Acid Transporter 1 Selective Liposomes of l-DOPA Functionalized Amphiphile for Combating Glioblastoma.
Bhunia S; Vangala V; Bhattacharya D; Ravuri HG; Kuncha M; Chakravarty S; Sistla R; Chaudhuri A
Mol Pharm; 2017 Nov; 14(11):3834-3847. PubMed ID: 28958145
[TBL] [Abstract][Full Text] [Related]
7. L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells.
Satou M; Wang J; Nakano-Tateno T; Teramachi M; Suzuki T; Hayashi K; Lamothe S; Hao Y; Kurata H; Sugimoto H; Chik C; Tateno T
Mol Cell Endocrinol; 2020 Sep; 515():110868. PubMed ID: 32579901
[TBL] [Abstract][Full Text] [Related]
8. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells.
Nishikubo K; Ohgaki R; Okanishi H; Okuda S; Xu M; Endou H; Kanai Y
J Cell Mol Med; 2022 Oct; 26(20):5246-5256. PubMed ID: 36071551
[TBL] [Abstract][Full Text] [Related]
10. L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity.
Rii J; Sakamoto S; Mizokami A; Xu M; Fujimoto A; Saito S; Koike H; Tamura T; Arai T; Yamada Y; Goto Y; Sazuka T; Imamura Y; Suzuki K; Kanai Y; Anzai N; Ichikawa T
Cancer Sci; 2024 Mar; 115(3):937-953. PubMed ID: 38186218
[TBL] [Abstract][Full Text] [Related]
11. Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203.
Brunocilla C; Console L; Rovella F; Indiveri C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835453
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
[TBL] [Abstract][Full Text] [Related]
13. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
[TBL] [Abstract][Full Text] [Related]
14. Analysis of L-leucine amino acid transporter species activity and gene expression by human blood brain barrier hCMEC/D3 model reveal potential LAT1, LAT4, B
Taslimifar M; Faltys M; Kurtcuoglu V; Verrey F; Makrides V
J Cereb Blood Flow Metab; 2022 Jan; 42(1):90-103. PubMed ID: 34427144
[TBL] [Abstract][Full Text] [Related]
15. L-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia.
Huttunen J; Peltokangas S; Gynther M; Natunen T; Hiltunen M; Auriola S; Ruponen M; Vellonen KS; Huttunen KM
Sci Rep; 2019 Sep; 9(1):12860. PubMed ID: 31492955
[TBL] [Abstract][Full Text] [Related]
16. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
[TBL] [Abstract][Full Text] [Related]
17. Conditional inactivation of the L-type amino acid transporter LAT1 in chondrocytes models idiopathic scoliosis in mice.
Iwahashi S; Lyu J; Tokumura K; Osumi R; Hiraiwa M; Kubo T; Horie T; Demura S; Kawakami N; Saito T; Park G; Fukasawa K; Iezaki T; Suzuki A; Tomizawa A; Ochi H; Hojo H; Ohba S; Hinoi E
J Cell Physiol; 2022 Nov; 237(11):4292-4302. PubMed ID: 36161979
[TBL] [Abstract][Full Text] [Related]
18. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
[TBL] [Abstract][Full Text] [Related]
19. Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor.
Okanishi H; Ohgaki R; Okuda S; Endou H; Kanai Y
Cancer Sci; 2021 Feb; 112(2):871-883. PubMed ID: 33264461
[TBL] [Abstract][Full Text] [Related]
20. Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.
Maimaiti M; Sakamoto S; Yamada Y; Sugiura M; Rii J; Takeuchi N; Imamura Y; Furihata T; Ando K; Higuchi K; Xu M; Sazuka T; Nakamura K; Kaneda A; Kanai Y; Kyprianou N; Ikehara Y; Anzai N; Ichikawa T
Sci Rep; 2020 Jan; 10(1):1292. PubMed ID: 31992742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]